Fulcrum Therapeutics

2 followers

‌

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.

Industries

Biotechnology, Education

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Alex C. Sapir

President, CEO & Board Member

Alex C. Sapir

Collapse

Mel Hayes

Chief Operating Officer

Curtis Oltmans

Chief Legal Officer

Kim Hazen

Chief People Officer

Jeff Jacobs

Chief Scientific Officer And Head Of Technical Operations

Alan Musso

Chief Financial Officer

Heather Faulds

Chief Regulatory Affairs & Quality Assurance Officer

Iain Fraser

SVP, Early Development

Thomas Winker

VP, Hematology Clinical Development

Bassel Iskandarani

Head Of Drug Product Development

Swathi Srivatsa

Senior Director, New Product Planning & FSHD Brand Lead

Teams

Scientific Research and Development

7 members

Operations and Development

9 members

Board Governance Team

8 members

Clinical Affairs Team

2 members

Leadership Team

3 members

Medical and Clinical Operations

4 members

Offices

Similar companies

Akoya Biosciences

2 followers

Tune Therapeutics

1 follower

insitro

6 followers

Regulus Therapeutics

1 follower

REVOLUTION Medicines

5 followers

Immunovant

5 followers

Summit Therapeutics

5 followers

Product School

5 followers

Dyne Therapeutics

3 followers

Viridian Therapeutics

2 followers

Vaxart

2 followers

Explore companies